Wang Peng, Wang Shidong, Liu Zhimin, Song Lei, Xu Bo, Dou Kefei, Wu Yongjian, Qiao Shubin, Gao Runlin, Zhao Gang, Huang Mi, Hu Xuemei, Wang Hao, Xu Xuelian, Yang Yuejin
Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China.
Department of Cardiology, Linyi People's Hospital of Shandong Province, 251500 Dezhou, Shandong, China.
Rev Cardiovasc Med. 2023 Jun 19;24(6):179. doi: 10.31083/j.rcm2406179. eCollection 2023 Jun.
Patients with acute myocardial infarction (AMI) complicated with arrhythmia are not uncommon. Insertion of temporary pacemakers (tPMs) in patients with arrythmia during acute myocardial infarction (AMI) is imperative support therapy. Arrhythmias include high-degree atrioventricular block (AVB), sinus arrest/bradycardia, and ventricular arrythmia storm. To date, no study has evaluated the prognosis of tPMs in patients with AMI complicated with arrhythmia. Especially in the era of thrombolysis or emergency percutaneous coronary intervention (PCI) for coronary artery revascularization, our study was designed to investigate the value of tPMs implantation in cases of AMI complicated with various arrhythmias.
From January 2009 to January 2019, 35,394 patients with AMI, including 62.0% (21,935) with ST-segment elevation myocardial infarction (STEMI) and 38.0% (13,459) with non-ST-segment elevation myocardial infarction (NSTEMI) in four hospitals, were reviewed. A total of 552 patients with AMI associated with arrythmia were included in the cohort. Among the 552 patients, there were 139 patients with tPM insertions. The incidence trend of myocardial infarction complicated with various arrhythmias in the past 10 years was analysed, and the clinical characteristics, in-hospital mortality, postdischarge mortality, composite endpoints of modality, and independent risk factors were compared in patients with and without tPM in the era of coronary artery revascularization.
In patients with AMI-associated arrythmia, high-degree AVB was the major cause of tPM insertion ( = 0.045). In the past 10 years, the number of patients with high-degree AVB, tPM implantation, ventricular arrythmia storm, and in-hospital mortality has decreased year by year in the era of coronary artery revascularization. In the tPM group, the culprit vessel was the left main artery, and cardiogenic shock, acute renal injury and high brain natriuretic peptide (BNP) levels were independent risk factors for patients with AMI complicated with arrhythmia. The in-hospital mortality in the tPM group was higher than that in the non-tPM group. The patients with tPM insertion showed better postdischarge survival than patients without tPM insertion.
In the era of emergency thrombolysis or PCI, coronary revascularization can ameliorate the prognosis of patients with AMI complicated with various arrhythmias. Temporary pacemaker insertion in patients with AMI complicated with arrhythmia can reduce the postdischarge mortality of these patients.
急性心肌梗死(AMI)合并心律失常的患者并不少见。在急性心肌梗死(AMI)期间为心律失常患者插入临时起搏器(tPMs)是必要的支持治疗。心律失常包括高度房室传导阻滞(AVB)、窦性停搏/心动过缓以及室性心律失常风暴。迄今为止,尚无研究评估tPMs在AMI合并心律失常患者中的预后。特别是在冠状动脉血运重建的溶栓或急诊经皮冠状动脉介入治疗(PCI)时代,我们的研究旨在探讨tPMs植入在AMI合并各种心律失常病例中的价值。
回顾2009年1月至2019年1月在四家医院的35394例AMI患者,其中ST段抬高型心肌梗死(STEMI)患者占62.0%(21935例),非ST段抬高型心肌梗死(NSTEMI)患者占38.0%(13459例)。共有552例AMI合并心律失常患者纳入队列。在这552例患者中,有139例插入了tPMs。分析过去10年心肌梗死合并各种心律失常的发病趋势,并比较冠状动脉血运重建时代有tPMs和无tPMs患者的临床特征、院内死亡率、出院后死亡率、综合终点指标以及独立危险因素。
在AMI合并心律失常患者中,高度AVB是插入tPMs的主要原因( = 0.045)。在过去10年中,冠状动脉血运重建时代高度AVB、tPMs植入、室性心律失常风暴及院内死亡率的患者数量逐年下降。在tPMs组中,罪犯血管为左主干动脉,心源性休克、急性肾损伤和高脑钠肽(BNP)水平是AMI合并心律失常患者的独立危险因素。tPMs组的院内死亡率高于非tPMs组。插入tPMs的患者出院后的生存率优于未插入tPMs的患者。
在急诊溶栓或PCI时代,冠状动脉血运重建可改善AMI合并各种心律失常患者的预后。AMI合并心律失常患者插入临时起搏器可降低这些患者的出院后死亡率。